SeekingAlpha · Sep 22, 2026
Gabelli Healthcare & WellnessRX Trust Q2 2026 Commentary
The Gabelli Healthcare & Wellness Trust is a diversified, closed-end management investment company whose investment objective is long-term growth of capital.
GR
NYSE · GRX
The Gabelli Healthcare & Wellness Trust
Financial Services · Asset Management
$9.42
Up+$0.03 (+0.32%)
Updated Oct 7, 2026, 12:17 PM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 151.54M
- P/E ratio
- -215.13
- Dividend yield
- 8.60%
- 52-week range
- $8.80 – $10.20
- Volume
- 12.39K
- Avg. volume
- 34.22K
Price performance · GRX
GRX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
GRX closed at $9.42 after 21 trading sessions, down 5.14% for the selected period.
- Last close
- $9.42
- Period change
- -5.14%
- Period low
- $9.38
- Period high
- $9.93
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $9.3286 | $9.4899 | $9.3286 | $9.42 | 12.39K |
| Oct 5, 2026 | $9.33 | $9.40 | $9.28 | $9.39 | 7.1K |
| Oct 2, 2026 | $9.42 | $9.5899 | $9.35 | $9.375 | 7.24K |
| Oct 1, 2026 | $9.51 | $9.535 | $9.33 | $9.42 | 24.22K |
| Sep 30, 2026 | $9.61 | $9.6112 | $9.51 | $9.51 | 11.47K |
| Sep 29, 2026 | $9.59 | $9.635 | $9.56 | $9.57 | 6.25K |
| Sep 28, 2026 | $9.66 | $9.69 | $9.58 | $9.61 | 7.67K |
| Sep 25, 2026 | $9.86 | $9.86 | $9.64 | $9.67 | 22.76K |
| Sep 24, 2026 | $9.77 | $9.9015 | $9.7166 | $9.83 | 19.76K |
| Sep 23, 2026 | $9.80 | $9.88 | $9.75 | $9.80 | 61.07K |
| Sep 22, 2026 | $9.68 | $9.75 | $9.63 | $9.72 | 24.59K |
| Sep 21, 2026 | $9.61 | $9.65 | $9.61 | $9.64 | 17.45K |
| Sep 18, 2026 | $9.61 | $9.6604 | $9.60 | $9.63 | 15.59K |
| Sep 17, 2026 | $9.65 | $9.735 | $9.6163 | $9.66 | 19.91K |
| Sep 16, 2026 | $9.62 | $9.735 | $9.5905 | $9.66 | 31.18K |
| Sep 15, 2026 | $9.86 | $9.8957 | $9.74 | $9.74 | 41.86K |
| Sep 14, 2026 | $9.74 | $9.8999 | $9.74 | $9.85 | 11.02K |
| Sep 11, 2026 | $9.79 | $9.79 | $9.71 | $9.72 | 10.96K |
| Sep 10, 2026 | $9.86 | $9.86 | $9.71 | $9.74 | 27.42K |
| Sep 9, 2026 | $9.89 | $9.92 | $9.89 | $9.89 | 26.53K |
| Sep 8, 2026 | $9.98 | $10.00 | $9.92 | $9.93 | 25.27K |
Latest GRX news
The latest Smart Investors Daily articles mentioning GRX.
Stock researchCompany · Overview
Company
Market Activity
Research & News
GRX research
Overview
Company profile and research snapshot.
Company profile
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
SeekingAlpha · Jun 23, 2026
Gabelli Healthcare & WellnessRX Trust Q1 2026 Commentary
The Gabelli Healthcare & Wellness RX Trust is a diversified, closed-end management investment company whose investment objective is long-term growth of capital. Read more here.
SeekingAlpha · Feb 2, 2026
GRX: Underwhelming Performance Metrics And Inconsistent Dividend Coverage
Gabelli Healthcare & WellnessRx Trust fund analysis: 7% yield but weak NII, NAV erosion and rate sensitivity. Read here for more on GRX CEF.
seekingalpha.com · Nov 14, 2025
Gabelli Healthcare & Wellness Trust Q3 2025 Commentary
Gabelli Healthcare & WellnessRx Trust is a diversified, closed-end management investment company whose investment objective is long-term growth of capital. Healthcare stocks rose during the quarter but continued to lag the broader stock market. On the consumer side, the food industry continued to face headwinds from the cumulative effect of inflation on consumer spending as well as lower consumption due to widespread adoption of GLP-1 weight loss.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
